CTLA4 and cancer: Finally, a retrospective Kaiser Permanente database search in Southern California revealed a higher 1-year incidence of uveitis in patients on ICIs who had a diagnosis of melanoma (1.2% overall, largely driven by CTLA-4 targets) over non-melanoma cancer (0.2%, Odds Ratio of 6.45) (21).